With the help of Lloyd, the only female, fellowship-trained breast surgeon in the region, and a team of obstetricians, radiologists and oncologists, they moved forward with the right plan of action for both Shaunta and her unborn son, Max.
"The research indicates that for the majority of patients, particularly in their second trimester, chemotherapy is relatively safe for the fetus," explained Lloyd.
"We just hit it head on because we wanted the best for sweet little Max," said Shaunta.
Max Chamberlin was born 10 weeks early and spent three months in the medical center’s Neonatal Intensive Care Unit. Now he’s a healthy, happy two year old.
The medical center offered Shaunta a one-of-a-kind approach to cancer treatment. “Throughout Shaunta’s treatment journey," said Lloyd, "it was crucial that we continued strong collaboration not only between Shaunta’s care team at the Cancer Institute, but also with the Center for Women & Infants’ physicians responsible for her OB-GYN care and neonatologists who would be caring for Max."
Shaunta said, "Every time I saw one of my care team, they would have spoken to the others to be sure we were all on the same page about what was happening. It was like they had started a Shaunta and Max group chat!"
It was this multidisciplinary and multi-faceted approach, which spanned many different clinicians and departments, that gave both Shaunta and Max a safe and healthy delivery.